Cytomembrane-mimicking nanocarriers with a scaffold consisting of a CD44-targeted endogenous component for effective asparaginase supramolecule delivery. Issue 22 (1st June 2020)
- Record Type:
- Journal Article
- Title:
- Cytomembrane-mimicking nanocarriers with a scaffold consisting of a CD44-targeted endogenous component for effective asparaginase supramolecule delivery. Issue 22 (1st June 2020)
- Main Title:
- Cytomembrane-mimicking nanocarriers with a scaffold consisting of a CD44-targeted endogenous component for effective asparaginase supramolecule delivery
- Authors:
- Huang, Yongjia
Gu, Jing
Yan, Zijun
Hu, Xueyuan
He, Dan
Zhang, Yonghong
Li, Yao
Zhong, Cailing
Yang, Jie
Shi, Da
Abagyan, Ruben
Tan, Qunyou
Zhang, Jingqing - Abstract:
- Abstract : Cytomembrane-mimicking nanocarriers with a scaffold consisting of a CD44-targeted endogenous component were applied to effectively deliver asparaginase supramolecule. Abstract : Highly effective and safe delivery of therapeutic enzymes is pivotal to the success of antitumor therapy. Herein, we report on a targeted enzyme delivery system based on cytomembrane-mimicking nanocarriers (CmN) and a supramolecular technique (SmT). Specifically, each CmN had a scaffold that mainly consisted of a CD44-targeted endogenous component conjugated with polyethylene glycol 2000 (HA- g -PEG) that self-assembled with α-cyclodextrin (ACD). The CmN acted as a microbioreactor with an inner hollow space with the capacity to confine the large molecule asparaginase (Asp) in an Asp/ACD-supramolecular complex conjugated to the inner region. The supramolecular Asp loaded into the CmN (A-S-CmN) exhibited superior stability, kinetic properties, catalytic activity and antitumor effects compared to free Asp due to the dual protection of the supramolecular complex and the nanovesicle, the CD44 targeting-homing ability, the prolonged effects of HA- g -PEG, and the favorable inner microenvironment of the constructed supramolecular CmN. The A-S-CmN also showed a decrease in in vivo toxicity and immunogenicity. CmN combined with SmT therapeutics are easy to implement and extend for use in the delivery of various enzymes and for many types of cancer treatment.
- Is Part Of:
- Nanoscale. Volume 12:Issue 22(2020)
- Journal:
- Nanoscale
- Issue:
- Volume 12:Issue 22(2020)
- Issue Display:
- Volume 12, Issue 22 (2020)
- Year:
- 2020
- Volume:
- 12
- Issue:
- 22
- Issue Sort Value:
- 2020-0012-0022-0000
- Page Start:
- 12083
- Page End:
- 12097
- Publication Date:
- 2020-06-01
- Subjects:
- Nanoscience -- Periodicals
Nanotechnology -- Periodicals
620.505 - Journal URLs:
- http://www.rsc.org/Publishing/Journals/NR/Index.asp ↗
http://www.rsc.org/ ↗ - DOI:
- 10.1039/d0nr02588g ↗
- Languages:
- English
- ISSNs:
- 2040-3364
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9830.266000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 13828.xml